Duragesic Fentanyl Pain Patch lawyer
Casey Flynn is one of the chief litigating attorneys at Carey & Danis, www.careydanis.com, whose lawyers have recovered over $695 million for their clients, including individual settlements of over $10 million and class-wide settlements of over $90 million. Contact Casey Flynn right now about your Levaquin and Cipro case.
The fentanyl transdermal patch is supposed to avoid overdose by delivering the painkiller over an extended period of time. But this does not always happen. Duragesic Fentanyl Pain Patch
Pain patches containing the prescription painkiller fentanyl and sold under the brand name "Duragesic" and the generic fentanyl pain patch made by Sandoz have been recalled yet again due to a manufacturing defect. Since 2005, millions of fentanyl patches have been recalled due to possible tears that could allow gel to leak from the patches.
If the fentanyl gel comes into direct contact with the skin it poses a serious risk of fentanyl overdose—which could mean respiratory failure, permanent coma and even death.The problem with using these very strong painkillers is the danger of overdose, which can occur when the drug is administered too quickly, in excessive dosages, through direct exposure because of a manufacturing defect, or to patients who are sensitive to opiate-based drugs.
Symptoms of overdose can include:
- Slow breathing
- Tiredness
- Confusion
- Cold and clammy skin
- Decreased pupil size
- Dizziness or weakness
- Loss of consciousness or coma
The Food and Drug Administration began taking action in connection with the transdermal patches, issuing recalls and demands for labeling changes. Among the potentially-lethal dangers of the fentanyl transdermal patches are that overdoses can occur when patches are cut, damaged, or defective. The fentanyl transdermal patches have been linked to respiratory depression, respiratory arrest, and even death.
In 2004, the FDA warned fentanyl pain patch users of the high danger of overdose because of leakage, and initiated the first of what would soon prove be multiple recalls of patches made by Johnson & Johnson subsidiaries. In 2005, the FDA stated in a Public Health Advisory that it had received 120 reports of deaths related to fentanyl patches.
Contact our lawyers at 314-678-1207 or Click here for Free Evaluation of your case.
Casey Flynn is one of the chief litigating attorneys at Carey & Danis, www.careydanis.com, whose lawyers have recovered over $695 million for their clients, including individual settlements of over $10 million and class-wide settlements of over $90 million. Contact Casey Flynn right now about your Levaquin and Cipro case.
The fentanyl transdermal patch is supposed to avoid overdose by delivering the painkiller over an extended period of time. But this does not always happen. Duragesic Fentanyl Pain Patch
Pain patches containing the prescription painkiller fentanyl and sold under the brand name "Duragesic" and the generic fentanyl pain patch made by Sandoz have been recalled yet again due to a manufacturing defect. Since 2005, millions of fentanyl patches have been recalled due to possible tears that could allow gel to leak from the patches.
If the fentanyl gel comes into direct contact with the skin it poses a serious risk of fentanyl overdose—which could mean respiratory failure, permanent coma and even death.The problem with using these very strong painkillers is the danger of overdose, which can occur when the drug is administered too quickly, in excessive dosages, through direct exposure because of a manufacturing defect, or to patients who are sensitive to opiate-based drugs.
Symptoms of overdose can include:
- Slow breathing
- Tiredness
- Confusion
- Cold and clammy skin
- Decreased pupil size
- Dizziness or weakness
- Loss of consciousness or coma
The Food and Drug Administration began taking action in connection with the transdermal patches, issuing recalls and demands for labeling changes. Among the potentially-lethal dangers of the fentanyl transdermal patches are that overdoses can occur when patches are cut, damaged, or defective. The fentanyl transdermal patches have been linked to respiratory depression, respiratory arrest, and even death.
In 2004, the FDA warned fentanyl pain patch users of the high danger of overdose because of leakage, and initiated the first of what would soon prove be multiple recalls of patches made by Johnson & Johnson subsidiaries. In 2005, the FDA stated in a Public Health Advisory that it had received 120 reports of deaths related to fentanyl patches.
Contact our lawyers at 314-678-1207 or Click here for Free Evaluation of your case.
